Visit Us @
Synergy Centre TU Dublin, Tallaght, D24A386
Mail Us @
info@codlad.com
Call Us @
+353 851890752

FDA

Coronavirus (COVID-19) Update: January 5, 2021

January 5, 2021

Coronavirus (COVID-19) Update: January 5, 2021

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, the FDA posted…

Coronavirus (COVID-19) Update: January 5, 2021 FDA
FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines

January 5, 2021

FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines

Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 disease in adults. As the first round of vaccine recipients…

FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines FDA
FDA Takes Steps to Provide Clarity on Developing New Drug Products in the Age of Individualized Medicine

January 4, 2021

FDA Takes Steps to Provide Clarity on Developing New Drug Products in the Age of Individualized Medicine

Advances in scientific knowledge and drug development technology have provided an opportunity for new approaches to drug development, including the development of drugs for the…

FDA Takes Steps to Provide Clarity on Developing New Drug Products in the Age of Individualized Medicine FDA

Latest Posts

FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
March 25, 2026
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
March 20, 2026
FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide
FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide
March 19, 2026